All conditions
Clinical Reasoning · 10 min · Student

Aplastic Anemia

The one-line truth

The bone marrow factory stops making red cells, white cells, and platelets — usually because the body's own immune cells attack the stem cells or toxic chemicals and drugs destroy them.

0% · 0/14

Phase 1 · Understand the Body — Why the disease behaves the way it does.

The One-Line Truth

The whole disease in one chain

Everything on this page exists to explain this line.

The bone marrow factory stops making red cells, white cells, and platelets — usually because the body's own immune cells attack the stem cells or toxic chemicals and drugs destroy them.

Factory shutdown with no backup inventory

Imagine a factory with three assembly lines (red cells, white cells, platelets) all fed by one pool of master workers (hematopoietic stem cells). The factory also has a support team (stromal cells) who keep the workspace clean, deliver supplies (growth factors like EPO, G-CSF, TPO), and manage the shipping dock (marrow blood vessels). In aplastic anemia, either the master workers get poisoned by a toxic chemical spill (drug, benzene, radiation), attacked by factory security that goes haywire (autoimmune T cells), infected by a virus that destroys them, or born with faulty tools (Fanconi anemia, dyskeratosis congenita). Once the master workers are gone, the assembly lines freeze—instantly. Because blood cells are fragile and live only days to months (red cells 120 days, platelets 7–10 days, neutrophils 6–8 hours), the inventory in the warehouse runs out fast. The factory has no way to make new workers, so production stays at zero. Unlike a real factory that could hire from outside, the bone marrow cannot import stem cells from anywhere else—it must regenerate them from within. That is why the disease is so dangerous: there is no backup plan.

Compare with a look-alike Print study sheet Full clinical PDF Patient teaching sheet

American Society of Hematology (ASH) guidelines on aplastic anemia · British Society for Haematology (BSH) 2016 guidelines for diagnosis and management of aplastic anemia · National Institutes of Health (NIH) consensus on acquired aplastic anemia · Aplastic Anemia and MDS International Foundation evidence-based standards · reviewed 2026-07-07

Install Maldek by Hill as an app — studies work even offline